1-Year Follow up to the 1473-IMIQ Study

Status Completed

Clinical Trial Summary

This is a 1-year follow-up study to evaluate the long-term effects in subjects who completely cleared their actinic keratosis (AK) lesions in the 1473-IMIQ study. The 1473-IMIQ study evaluated the safety and effectiveness of imiquimod 5% cream compared to a placebo cream for the treatment of AK.

Clinical Trial Description

n/a

Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00114023
Study type	Observational
Source	Graceway Pharmaceuticals, LLC
Contact
Status	Completed
Phase	Phase 3
Start date	January 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00239135` - Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel	Phase 2
Recruiting	`NCT06206681` - Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Completed	`NCT00115154` - Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands	Phase 4
Recruiting	`NCT04336514` - A Longitudinal Quantitative Assessment of the Effectiveness of Metatarsal Pads on Plantar Pressures	N/A
Completed	`NCT00116649` - Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis	Phase 4
Recruiting	`NCT05942794` - Identification of Oral Lesions Through an Autofluorescence System	N/A
Withdrawn	`NCT02851693` - Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / Resection	N/A
Withdrawn	`NCT02813902` - A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors	Phase 1
Completed	`NCT00121511` - The Effect of Efudex Treatment on Photoaged Skin	N/A
Completed	`NCT05060237` - Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp	Phase 1
Recruiting	`NCT02737176` - Tobacco Cessation Intervention Study for Oral Diseases	N/A
Completed	`NCT00110682` - Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses	Phase 4